Park, Kyung Chan http://orcid.org/0000-0001-7203-0127
Crump, Nicholas T. http://orcid.org/0000-0001-9610-6763
Louwman, Niamh
Krywawych, Steve
Cheong, Yuen Jian http://orcid.org/0009-0008-9450-2576
Vendrell, Iolanda
Gill, Eleanor K.
Gunadasa-Rohling, Mala
Ford, Kerrie L.
Hauton, David
Fournier, Marjorie
Pires, Elisabete
Watson, Lydia
Roseman, Gerald
Holder, James http://orcid.org/0000-0001-7597-3104
Koschinski, Andreas http://orcid.org/0000-0003-1876-3279
Carnicer, Ricardo
Curtis, M. Kate http://orcid.org/0000-0002-0096-8199
Zaccolo, Manuela
Hulikova, Alzbeta
Fischer, Roman http://orcid.org/0000-0002-9715-5951
Kramer, Holger B.
McCullagh, James S. O. http://orcid.org/0000-0003-4733-1205
Trefely, Sophie http://orcid.org/0000-0003-3816-6869
Milne, Thomas A. http://orcid.org/0000-0002-0413-4271
Swietach, Pawel http://orcid.org/0000-0002-9945-9473
Article History
Received: 20 June 2022
Accepted: 15 October 2023
First Online: 23 November 2023
Competing interests
: N.T.C. and T.A.M. are shareholders in and consultants for Dark Blue Therapeutics, Ltd. The remaining authors declare no competing interests.